comparemela.com
Home
Live Updates
Evaluating Work Productivity, Efficacy and Safety of Tildrak
Evaluating Work Productivity, Efficacy and Safety of Tildrak
Evaluating Work Productivity, Efficacy and Safety of Tildrakizumab in Patients With Plaque Psoriasis
Two posters presented at the 2023 Fall Clinical Dermatology Conference assessed phase 4 study findings on tildrakizumab in patients with moderate to severe plaque psoriasis.
Related Keywords
,
Clinical Dermatology Conference ,
Work Productivity ,
Activity Impairment Questionnaire ,
Psoriasis ,
Tildrakizumab ,
Safety And Efficacy ,
Psoriasis Treatments ,
Plaque Psoriasis ,